Alzheimer’s quick OK, take two: FDA offers Biogen, Eisai a shortcut to a possible lecanemab approval
John Carroll
via Endpoints https://endpts.com
July 6, 2022 at 01:35AM
Alzheimer’s quick OK, take two: FDA offers Biogen, Eisai a shortcut to a possible lecanemab approval